NCT06071520View on ClinicalTrials.gov

Andalusian Experience in the Use of Fostamatinib in Patients With ITP. FOSTASUR Study

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

April 1, 2023

Study Completion Date

June 30, 2023

Conditions
Primary Immune Thrombocytopenia
Interventions
DRUG

Fostamatinib

Patient treated with fostamatinib in the period described

Trial Locations (14)

11009

Hospital Puerta del Mar, Cadiz

11407

Hospital Universitario de Jerez de la Frontera, Jerez de la Frontera

11510

Hospital de Puerto Real, Puerto Real

18014

Hospital Universitario Virgen de las Nieves, Granada

18016

Hospital Universitario San Cecilio, Granada

21005

Hospital Universitario Juan Ramón Jiménez, Huelva

21660

Hospital de Riotinto, Minas de Ríotinto

23007

Hospital Universitario de Jaén, Jaén

29010

Hospital Regional Universitario de Málaga, Málaga

Hospital Virgen de la Victoria, Málaga

29400

Hospital de la Serranía de Ronda, Ronda

41009

Hospital Universitario Virgen Macarena, Seville

41013

Hospital Universitario Virgen del Rocío, Seville

41640

Hospital de la Merced de Osuna, Osuna

All Listed Sponsors
lead

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

OTHER